Biomedical Engineering Reference
In-Depth Information
301. Moghimi, S. M.; Szebeni, J. Stealth Liposomes and Long Circulating Nanoparticles: Critical
Issues in Pharmacokinetics, Opsonization and Protein-Binding Properties.
Prog. Lipid. Res.
2003,
42,
463-478.
302. Paciotti, G. F.; Myer, L.; Weinreich, D.; Goia, D.; Pavel, N.; McLaughlin, E.; Tamarkin, L.
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery.
Drug Deliv.
2004,
11,
169-183.
303. Parveen, S.; Sahoo, S. K. Long Circulating Chitosan/PEG Blended PLGA Nanoparticle for
Tumor Drug Delivery.
Eur. J. Pharm.
2011,
670,
372-383.
304. Patil, Y. B.; Swaminathan, S. K.; Sadhukha, T.; Panyam, J. The Use of Nanoparticle-Mediated
Gene Silencing and Drug Delivery to Overcome Tumor Drug Resistance.
Biomaterials
2010,
31,
358-365.
305. Portilla-Arias, J. P.; Garcia-Alvarez, M.; de Ilarduya, A. M.; Holler, E.; Galbis, J. A.; Munoz-
Guerra, S. Synthesis, Hydrodegradation and Drug Releasing Properties of Methyl Esters of
Fungal Poly(β, l-malic acid).
Macromol. Biosci.
2008,
8,
540-550.
306. Seju, U.; Kumar, A.; Sawani, K. K. Development and Evaluation of Olanzapine-Loaded
PLGA Nanoparticles for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.
Acta Biomater.
2011,
7,
4169-4176.
307. Chonn, A.; Semple, S. C.; Cullis, P. R. Association of Blood Proteins with Large Unilamellar
Liposomes In Vivo. Relation to Circulation Lifetimes.
J. Biol. Chem.
1992,
267,
18759-18765.
308. Linhardt, R. J. In
Controlled Release of Drugs
; Rosoff, M., Ed.; VCH Publishers: New York,
1989; pp 53-95.
309. Westesen, K.; Bunjes, H.; Koch, M. H. J. Physicochemical Characterization of Lipid Nanoparti-
cles and Evaluation of their Drug Loading Capacity and Sustained Release Potential.
J. Control.
Release
1997,
48,
223-236.
310. Yang, S.; Zhu, J.; Lu, Y.; Liang, B.; Yang, C. Body Distribution of Camptothecin Solid Lipid
Nanoparticles after Oral Administration.
Pharm. Res.
1999,
16,
751-757.
311.
Nanoparticles
; Kreuter, J., Ed.; M. Dekker: New York, 1994.
312. Panagiotou, T.; Fisher, R. J. Enhanced Transport Capabilities via Nanotechnologies: Impact-
ing Bioefficacy, Controlled Release Strategies, and Novel Chaperones.
J. Drug Deliv.
2011,
2011,
1-14.
313. Bulte, J. W.; Kraitchman, D. L. Iron Oxide MR Contrast Agents for Molecular and Cellular
Imaging.
NMR Biomed.
2004,
17,
484-499.
314. Gourley, P. L. Brief Overview of BioMicroNano Technologies.
Biotechnol. Prog.
2005,
21,
2-10.
315. Berna, J.; Leigh, D. A.; Lubomska, M.; Mendoza, S. M.; Perez, E. M.; Rudolf, P., et al. Mac-
roscopic Transport by Synthetic Molecular Machines.
Nat. Mater.
2005,
4,
704-710.
316. Bonham, A. J.; Braun, G.; Pavel, I.; Moskovits, M.; Reich, N. Detection of Sequence-Specific
Protein-DNA Interactions Via Surface Enhanced Resonance Raman Scattering.
J. Am. Chem.
Soc.
2007,
129,
14572-14573.
317. Garcia, J. T.; Farina, J. B.; Munguia, O.; Llabres, M. Comparative Degradation Study of Bio-
degradable Microspheres of Poly(DL-lactide-co-glycolide) with Poly(ethyleneglycol) Deri-
vates.
J. Microencapsul.
1999,
16,
83-94.
318. Panyam, J.; Williams, D.; Dash, A.; Leslie-Pelecky, D.; Labhasetwar, V. Solid-state Solubility
Influences Encapsulation and Release of Hydrophobic Drugs from PLGA/PLA Nanoparticles.
J. Pharm. Sci.
2004,
93,
1804-1814.
319. Soma, C. E.; Dubernet, C.; Bentolila, D.; Benita, S.; Couvreur, P. Reversion of Multidrug
Resistance by Co-encapsulation of Doxorubicin and Cyclosporin A in Polyalkylcyanoacrylate
Nanoparticles.
Biomaterials
2000,
21,
1-7.
